CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Takara Bio Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Takara Bio Inc
7-4-38, Noji-Higashi
Phone: +81 775656920p:+81 775656920 KUSATSU-SHI, SHG  525-0058  Japan Ticker: 49744974
This is a Subsidiary, click here for the Parent Company
Business Summary
TAKARA BIO INC. is a Japan-based company principally engaged in bio-industry support business and gene medicine business. The Company operates in three business segments. Bioindustry Support segment provides reagents for research (genetic engineering reagents, cell engineering reagents, protein engineering reagents), scientific instruments, contract services and license fees for gene related patents to research institutes, such as universities and companies where biotechnology research and development are conducted. Gene Medicine segment provides gene therapy-related development and sale licensing fees and trial products as an application field of genetic engineering technology and cell engineering technology which is core technology cultivated in development of research reagents. Medical Food and Biotechnology segment provides health food and health food research and development services, license fees for health food related patents, as well as license fees for mushrooms.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20233/31/2023Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
3826 Laboratory analytical instruments

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Executive President, Chief Executive Officer, President of Subsidiary, Representative Di KoichiNakao 61 4/1/2020 4/1/2002
Executive Vice President, Vice President, Director JunichiMineno 63 6/1/2023 6/1/2012
Senior Managing Director, Senior Managing Executive Officer YohHamaoka 60 6/1/2023 4/1/2004
11 additional Officers and Directors records available in full report.

Business Names
Business Name
4974
Cellectis AB
Rubicon Genomics, Inc.
Takara Bio Inc.
WaferGen Bio-systems, Inc.

General Information
Number of Employees: 1,793 (As of 3/31/2023)
Outstanding Shares: 120,415,600 (As of 12/31/2023)
Shareholders: 42,926
Stock Exchange: TYO
Fax Number: +81 775618007


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024